Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.4 is now listed as the latest version in the revision history, replacing the previous v3.5.3 entry. This reflects an update to the page's internal versioning information.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s version/revision label has been updated from v3.5.2 to v3.5.3, indicating an internal site update rather than a change to the clinical trial record details.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check62 days agoChange DetectedThe Record History now shows a new revision entry v3.5.0 and the previous entry v3.4.3 has been removed. No study data or results are changed.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the study record history.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 was added to the history, and the funding-status notice along with Revision: v3.4.1 were removed.SummaryDifference0.9%

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.